Fenuron

Fenuron

SCHEMBL427377

CC(C)(C)C(=O)O.CN(C)C(=O)Nc1ccccc1

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.55
TP53 P04637 1/20 0.53
MTOR P42345 1/20 0.51
ALDH1A1 P00352 1/20 0.49
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
ATM Q13315 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fenuron SCHEMBL10806698 0.90 TSHR (0.64) TSHRMTOR
Fenuron SCHEMBL8366971 0.90 TSHR (0.64) TSHRMTOR
Fenuron SCHEMBL9451054 0.90 TSHR (0.64) TSHRMTOR
Fenuron SCHEMBL62004 0.90 TSHR (0.64) TSHRMTOR
Fenuron SCHEMBL163653 0.87 TSHR (0.58) TSHRTP53MTORALDH1A1MAPT
Fenuron SCHEMBL28146684 0.85 TSHR (0.58) TSHRMTOR
SCHEMBL9479416 0.83 MAPT (0.63) TSHRALDH1A1MAPT
Fenuron SCHEMBL6304636 0.83 TSHR (0.56) TSHRMTORATM
Fenuron SCHEMBL9755759 0.81 GAA (0.61) TSHRMTORMAPTATM
Fenuron SCHEMBL11407093 0.80 MTOR (0.48) TSHRTP53MTORALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 767 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3578542-B1 COMPOSITIONS HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-11-12 EP claimed
EP-3578543-B1 COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-08-20 EP claimed
EP-4593598-A1 STORAGE-STABLE COMPOSITIONS INCLUDING BIXLOZONE AND BEFLUBUTAMID FMC Corporation (US) 2025-08-06 EP claimed
EP-3578541-B1 COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-05-28 EP claimed
WO-2024073019-A1 STORAGE-STABLE COMPOSITIONS INCLUDING BIXLOZONE AND B EFLUB UT AMID FMC CORPORATION (US) 2024-04-04 WO claimed
EP-4096400-A1 LIQUID SULFONYLUREA COMPOSITIONS FMC Agricultural Caribe Industries Ltd. (BM) 2022-12-07 EP claimed
WO-2021152391-A1 LIQUID SULFONYLUREA COMPOSITIONS FMC AGRICULTURAL CARIBE INDUSTRIES LTD. (BM) 2021-08-05 WO claimed
EP-3407717-B1 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO DOW AGROSCIENCES LLC (US) 2021-07-28 EP claimed
CN-108697091-B Molecules having pesticidal utility, and intermediates, compositions and methods related thereto 美国陶氏益农公司 2021-07-23 CN claimed
EP-3407716-B9 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2021-07-14 EP claimed
EP-2934135-B1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2018-01-31 EP claimed
US-20170044565-A9 Soybean Event DP-305423-1 And Compositions And Methods For The Identification And/Or Detection Thereor E. I. DU PONT DE NEMOURS AND COMPANY (US) 2017-02-16 US claimed
US-20140100110-A1 Soybean Event DP-305423-1 And Compositions And Methods For The Identification And/Or Detection Thereor E. I. DU PONT DE NEMOURS AND COMPANY (US) 2014-04-10 US claimed
US-8609935-B2 Soybean event DP-305423-1 and compositions and methods for the identification and/or detection thereof E. I. DU PONT DE NEMOURS AND COMPANY (US) 2013-12-17 US claimed
CN-101460533-B Reverse phase microcapsules for active ingredients, simplified preparation method thereof and combination formulations WDG-CS, ZC, EC-SC and CX GAT MICROENCAPSULATION AG 2013-10-23 CN claimed
US-8337900-B2 Reverse-phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulation WDG-CS, ZC, EC-SC, and CX FMC CORPORATION 2012-12-25 US claimed
CN-101460533-A Reverse phase microcapsules for active ingredients, simplified preparation method thereof and combination formulations WDG-CS, ZC, EC-SC and CX GAT MICROENCAPSULATION AG (AT) 2009-06-17 CN claimed
EP-2004718-A1 REVERSE-PHASE MICROCAPSULES FOR ACTIVE INGREDIENTS, SIMPLIFIED PROCESS OF MANUFACTURE THEREOF AND COMBINED FORMULATIONS WDG-CS, ZC, EC-SC AND CX GAT Microencapsulation AG (AT) 2008-12-24 EP claimed
US-20080312082-A1 SOYBEAN EVENT DP-305423-1 AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND/OR DETECTION THEREOF CORTEVA AGRISCIENCE LLC 2008-12-18 US claimed
WO-2007112933-A1 REVERSE-PHASE MICROCAPSULES FOR ACTIVE INGREDIENTS, SIMPLIFIED PROCESS OF MANUFACTURE THEREOF AND COMBINED FORMULATIONS WDG-CS, ZC, EC-SC AND CX GAT MICROENCAPSULATION AG (AT) 2007-10-11 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312082-A1 SOYBEAN EVENT DP-305423-1 AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND/OR DETECTION THEREOF DPY30, O60361, DPYSL3 TSHR 4809/4885TP53 1171/4885MTOR 4429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.